The law firm of Gracin & Marlow, LLP with offices in New York City and in Boca Raton, Florida,
represents diverse clients throughout the United States and the world in connection with corporate
and securities transactions, mergers & acquisitions, crowdfunding, reverse mergers and self-filings, IPOs, APOs, registered direct offerings, PIPE transactions, Regulation A+ and EB-5 program, venture capital and angel investor financings, exchange and market listings, blue sky laws, licensing agreements, and other intellectual property acquisitions.

Our competitive strength is our ability to bring our years of experience at top New York firms to
provide creative answers and personal attention to solve complex issues at a reasonable cost.
Our clients include publicly traded companies, investment banking firms, securities underwriters,
entrepreneurs, start-up companies, emerging companies and established companies across a wide
range of industries.

As featured on CNBC, click here to view.

Gracin and Marlow has been named a Designated Advisor For Disclosure (DADs) & Principal American Liaisons (PALs) by OTCQX. Read the press release on market watch.

Filed 08/31/16, FORM S-8

SYNTHETIC BIOLOGICS, INC. – Represented the issuer in connection with the registration of 6,000,000 shares of common stock under its 2010 Stock Incentive Plan.

Filed 08/17/16, FORM S-8

ICAGEN, INC. – Represented the issuer in connection with the registration of 790,770 shares of common stock under the Caldera Pharmaceuticals, Inc. 2005 Stock Option Plan and 800,000 shares of common stock under its 2015 Stock Incentive Plan.

Filed 08/15/16, FORM S-8

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of 1,900,000 shares of common stock under its 2014 Stock Incentive Plan.

Filed 08/15/16, FORM 424B5

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.